Biblio
Export 1921 results:
Author Title Type [ Year![(Asc)](https://www.j-alz.com/sites/all/modules/contrib/biblio/misc/arrow-asc.png)
Filters: First Letter Of Last Name is B [Clear All Filters]
“Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1097-1113, 2023.
, “Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.”, J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.
, “Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1587-1605, 2023.
, “Effects of a Physical Activity Program that Incorporates Exercises Targeting Balance, Strength, and Proprioception on Cognitive Functions and Physical Performance in Old Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 96, no. 1, pp. 245-260, 2023.
, “Effects of a Physical Activity Program that Incorporates Exercises Targeting Balance, Strength, and Proprioception on Cognitive Functions and Physical Performance in Old Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 96, no. 1, pp. 245-260, 2023.
, “The Efficacy and Safety of Physiotherapy in People with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 94, no. 3, pp. 909-917, 2023.
, “The Efficacy and Safety of Physiotherapy in People with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 94, no. 3, pp. 909-917, 2023.
, “Elevated Pure Tone Thresholds Are Associated with Altered Microstructure in Cortical Areas Related to Auditory Processing and Attentional Allocation.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1163-1172, 2023.
, “Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1057-1074, 2023.
, “Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1057-1074, 2023.
, “Extracellular Tau Oligomers Damage the Axon Initial Segment.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1425-1441, 2023.
, “Extracellular Tau Oligomers Damage the Axon Initial Segment.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1425-1441, 2023.
, “From Association to Intervention: The Alzheimer's Disease-Associated Processes and Targets (ADAPT) Ontology.”, J Alzheimers Dis, vol. 94, no. s1, pp. S87-S96, 2023.
, “Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 3, pp. 1135-1151, 2023.
, “Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 3, pp. 1135-1151, 2023.
, “Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1047-1056, 2023.
, “Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1229-1239, 2023.
, “The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.”, J Alzheimers Dis, vol. 95, no. 2, pp. 703-718, 2023.
, “Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 2, pp. 813-825, 2023.
, “Linking Air Pollution Exposure to Blood-Based Metabolic Features in a Community-Based Aging Cohort with and without Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1025-1040, 2023.
, “Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 91, no. 1, pp. 273-290, 2023.
, “Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1051-1058, 2023.
, “Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1051-1058, 2023.
, “Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.”, J Alzheimers Dis, vol. 94, no. 1, pp. 259-279, 2023.
, “Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1505-1514, 2023.
,